ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,85
0,00%
Bitcoin
61 008,40
1,15%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adamas Pharmaceuticals Inc (ADMS)

  7. Adamas Pharmaceuticals Inc (ADMS) Actualités

ADMS

Adamas Pharmaceuticals (ADMS)

Adamas Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ADMS
DateHeureSourceTitreSymboleSociété
15/02/202212h35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
02/12/202112h15Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202122h12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202117h54Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202115h28Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202115h18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202115h17Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
24/11/202115h12GlobeNewswire Inc.Supernus Pharmaceuticals Completes Acquisition of Adamas PharmaceuticalsNASDAQ:ADMSAdamas Pharmaceuticals Inc
23/11/202114h22Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ADMSAdamas Pharmaceuticals Inc
23/11/202114h00GlobeNewswire Inc.Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender OfferNASDAQ:ADMSAdamas Pharmaceuticals Inc
10/11/202122h03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMSAdamas Pharmaceuticals Inc
01/11/202121h55Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
25/10/202117h26Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:ADMSAdamas Pharmaceuticals Inc
25/10/202116h22Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ADMSAdamas Pharmaceuticals Inc
19/10/202122h27Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ADMSAdamas Pharmaceuticals Inc
12/10/202113h56Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:ADMSAdamas Pharmaceuticals Inc
11/10/202112h30GlobeNewswire Inc.Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product PortfolioNASDAQ:ADMSAdamas Pharmaceuticals Inc
08/10/202122h15Business WireAdamas Announces New Employment Inducement GrantsNASDAQ:ADMSAdamas Pharmaceuticals Inc
01/10/202115h15Business WireAdamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health AwardsNASDAQ:ADMSAdamas Pharmaceuticals Inc
16/09/202115h15Business WireAdamas Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society’s (MDS) CongressNASDAQ:ADMSAdamas Pharmaceuticals Inc
30/08/202122h11Business WireAdamas to Present at Upcoming September Investor ConferencesNASDAQ:ADMSAdamas Pharmaceuticals Inc
13/08/202122h16Business WireAdamas Announces New Employment Inducement GrantNASDAQ:ADMSAdamas Pharmaceuticals Inc
09/08/202122h01Business WireAdamas Reports Second Quarter 2021 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
02/08/202122h02Business WireAdamas to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021NASDAQ:ADMSAdamas Pharmaceuticals Inc
22/07/202115h15Business WireAdamas Announces Issuance of New Patents for GOCOVRI and ADS-4101NASDAQ:ADMSAdamas Pharmaceuticals Inc
08/07/202122h02Business WireAdamas to Present at Upcoming William Blair Biotech Focus ConferenceNASDAQ:ADMSAdamas Pharmaceuticals Inc
23/06/202122h42Business WireAdamas to Present at Upcoming SVB Leerink CNS ForumNASDAQ:ADMSAdamas Pharmaceuticals Inc
10/06/202115h15Business WireNew Data Analysis Supports GOCOVRI as an Important Treatment for Motor Complications for People With Parkinson’s DiseaseNASDAQ:ADMSAdamas Pharmaceuticals Inc
27/05/202122h11Business WireAdamas to Present at Upcoming June ConferencesNASDAQ:ADMSAdamas Pharmaceuticals Inc
10/05/202122h02Business WireAdamas Reports First Quarter 2021 Financial ResultsNASDAQ:ADMSAdamas Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADMS

Dernières Valeurs Consultées

BOV
F2NV34
FrancNevada
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés